Vaccination against covid-19 is safer than infection
Juan Monino/Getty Images
Recent findings highlight that vaccinating children is more beneficial than exposing them to the coronavirus. A comprehensive study involving nearly 14 million children revealed that the likelihood of experiencing serious, albeit uncommon, side effects related to the heart and blood vessels was considerably greater following an infection compared to a vaccination.
Specifically, children aged 5 to 18 experienced 17 additional infections per 100,000 with inflammatory conditions such as Kawasaki disease in the six months after contracting SARS-CoV-2, as opposed to other periods. Conversely, among children first vaccinated with the Pfizer/BioNTech mRNA vaccine, infections per 100,000 dropped by almost two.
Myocarditis, which is inflammation of the heart muscle, resulted in over two extra cases per 100,000 individuals in the six months post-infection. In comparison, there was less than one additional case among vaccinated individuals, indicating that the risk of myocarditis is more than double following infection relative to vaccination.
A report highlighting a new coronavirus infection causing myocarditis has been made known. As early as April 2020, reports began surfacing even after vaccinations commenced in December. Vaccines associated with myocarditis tend to present milder symptoms, particularly in young men, and most individuals recover swiftly.
The uncommon side effects of this vaccine have garnered substantial media focus and stirred significant concern, contributing to delays in introducing routine childhood vaccinations in the UK until April 2022.
The latest findings reinforce earlier research indicating that vaccinated children face a lower risk of myocarditis compared to their unvaccinated peers, despite the rarity of this side effect. A majority of children contracted the virus, placing them at an elevated risk of adverse effects.
“It’s important to note that severe complications are highly uncommon among children and adolescents in general,” states Angela Wood from Cambridge, UK, a part of the HDR UK regional network. “Nevertheless, evidence suggests that the risk is generally higher following COVID-19 compared to vaccination.”
Wood’s team evaluated data from the UK’s National Health Service (NHS) encompassing approximately 14 million children under 18 from January 2020 to December 2021. During the latter half of this timeframe, 3.9 million children received the Pfizer/BioNTech vaccine, while 3.4 million were diagnosed with COVID-19 for the first time. Subsequent periods could not be analyzed due to insufficient testing.
This approach does have its limitations. For instance, the data does not indicate whether children who experienced these complications made a full recovery, and many mild COVID-19 cases amongst children may not have been formally recognized. “However, despite these constraints, the scale of the data and the comprehensive connection across all NHS data instills great confidence in our overall conclusions today,” says Wood.
“It’s crucial to understand that findings relevant to the strain of the coronavirus prevalent during the peak of the pandemic may differ for the current strain,” advises William Whiteley from the University of Edinburgh, UK, who was not involved in the study. His team previously reported that COVID-19 vaccines reduce the risk of heart attacks and strokes for at least six months post-vaccination.
The fact that nearly all individuals, apart from very young children, now possess some level of immunity to COVID-19 means they may respond differently to both booster shots and reinfections, according to team members including Peer Hardelid from University College London. “Ongoing research is essential,” she emphasizes.
Topic:
Source: www.newscientist.com
